Loss of T-cadherin (CDH13, H-cadherin) expression in cutaneous squamous cell carcinoma
about
sameAs
T-cadherin enhances cell-matrix adhesiveness by regulating beta1 integrin trafficking in cutaneous squamous carcinoma cellsDown-regulation of a novel actin-binding molecule, skeletrophin, in malignant melanomaDownregulation of expression of a novel cadherin molecule, T-cadherin, in basal cell carcinoma of the skinIdentification of T-cadherin as a novel target of DNA methyltransferase 3B and its role in the suppression of nerve growth factor-mediated neurite outgrowth in PC12 cellsReciprocal altered expression of T-cadherin and P-cadherin in psoriasis vulgaris.Involvement of members of the cadherin superfamily in cancerClinical significance of methylation of E-cadherin and p14ARF gene promoters in skin squamous cell carcinoma tissues.Differentially expressed genes between solitary large hepatocellular carcinoma and nodular hepatocellular carcinoma.A ubiquitin ligase, skeletrophin, is a negative regulator of melanoma invasion.Gene-gene interaction analysis identifies a new genetic risk factor for colorectal cancer.Adiponectin receptors, with special focus on the role of the third receptor, T-cadherin, in vascular disease.DNA hypermethylation, Her-2/neu overexpression and p53 mutations in ovarian carcinoma.Systems-level analysis of proteolytic events in increased vascular permeability and complement activation in skin inflammationCadherin 13 in cancer.Expression of ZNF396 in basal cell carcinoma.T-cadherin loss induces an invasive phenotype in human keratinocytes and squamous cell carcinoma (SCC) cells in vitro and is associated with malignant transformation of cutaneous SCC in vivo.T-cadherin modulates tumor-associated molecules in gallbladder cancer cells.A soluble truncated cadherin induces breast cancer cell apoptosis and growth inhibition.T-Cadherin Expression in the Epidermis and Adnexal Structures of Normal Skin.TLR4 as a negative regulator of keratinocyte proliferation.High T-cadherin expression is a feature of basal cell carcinoma.Genetic and epigenetic inactivation of T-cadherin in human hepatocellular carcinoma cells.Silencing of G0/G1 switch gene 2 in cutaneous squamous cell carcinoma.Aberrant Methylation Changes Detected in Cutaneous Squamous Cell Carcinoma of Immunocompetent Individuals.Tumor-specific downregulation and methylation of the CDH13 (H-cadherin) and CDH1 (E-cadherin) genes correlate with aggressiveness of human pituitary adenomas
P2860
Q24311576-C2F1FA90-4C05-4DF8-AB1A-BA9BD9E38BA1Q24685232-17EC7699-617B-4AD9-A090-8AF59F0F2478Q28218227-9235E113-EACF-4CC3-A696-3E12864B4D27Q28580458-6C0EC469-86DE-439F-843D-1DDB42A25571Q30977854-6FE1645A-4A7E-496B-A691-454DA2B5DEC2Q33899441-278E969B-26A2-4E42-B88C-457787C830DEQ34042261-87C84B69-3277-4162-82AC-05F6A4DC120BQ34366391-E7A66881-31BE-4C15-95B0-BCFC437B77E5Q34528954-7AA3D6C1-EC64-4B35-9E97-0CA99281C675Q36050189-58859749-D00E-4AA9-858D-AE58C6C2171BQ36943753-4E8A6E6C-E344-46EF-A912-180EFB37B6E3Q37097138-40CA6F19-5197-4F26-AF66-87E5F2C14767Q37412450-EA5CDCA6-69FD-4950-AA8E-35019C155CEDQ37770472-12CCDEAE-9094-4DA6-A2FC-E6045C6956CCQ39032566-3F23F621-4EB0-42F4-99B0-F0B65F2714A4Q39714441-44243BBA-8366-4696-B5A0-04F4D02365DCQ39745464-A0424B80-261D-41DE-B03E-FDAAF466940AQ40269659-54AC7F25-C265-474A-A486-E2FCB7689BBBQ41948588-083DBCCA-1830-46B4-9C09-9101FA3ED7B7Q42370733-25A33A12-EB38-405E-B2FC-8057ACF28A11Q42453623-A1C9B7DF-662B-4CCB-B1B1-FDECD2F49B11Q46540672-2E2B9717-DEC0-4FE1-8CB3-70BD4EE8D7F5Q47600127-81D97F6B-E6DE-4ADD-A504-2E94A1B2735DQ55068767-F4212534-A7D1-468D-8494-0F4575A7B874Q57794449-B8850057-F0C2-498B-8403-7B96631F0CF2
P2860
Loss of T-cadherin (CDH13, H-cadherin) expression in cutaneous squamous cell carcinoma
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Loss of T-cadherin (CDH13, H-cadherin) expression in cutaneous squamous cell carcinoma
@ast
Loss of T-cadherin (CDH13, H-cadherin) expression in cutaneous squamous cell carcinoma
@en
Loss of T-cadherin (CDH13, H-cadherin) expression in cutaneous squamous cell carcinoma
@nl
type
label
Loss of T-cadherin (CDH13, H-cadherin) expression in cutaneous squamous cell carcinoma
@ast
Loss of T-cadherin (CDH13, H-cadherin) expression in cutaneous squamous cell carcinoma
@en
Loss of T-cadherin (CDH13, H-cadherin) expression in cutaneous squamous cell carcinoma
@nl
prefLabel
Loss of T-cadherin (CDH13, H-cadherin) expression in cutaneous squamous cell carcinoma
@ast
Loss of T-cadherin (CDH13, H-cadherin) expression in cutaneous squamous cell carcinoma
@en
Loss of T-cadherin (CDH13, H-cadherin) expression in cutaneous squamous cell carcinoma
@nl
P2093
P2860
P3181
P1476
Loss of T-cadherin (CDH13, H-cadherin) expression in cutaneous squamous cell carcinoma
@en
P2093
Hiroshi Sonobe
Norihisa Matsuyoshi
Sheng-Ben Liang
Shuxia Zhou
Tamotsu Takeuchi
Yoshiki Miyachi
Yuji Ohtsuki
P2860
P304
P3181
P356
10.1097/01.LAB.0000025391.35798.F1
P407
P577
2002-08-01T00:00:00Z
P5875
P6179
1002878974